tirzepatide and lightheadedness Lilly releases Zepbound® (tirzepatide) single-dose vials, expanding supply access for adults living with obesity Tirzepatide is a modern injectable

This exclusivity is commercially significant

We continued therapy with closer monitoring

Impact of type 1 diabetes in the developing brain in children: a longitudinal study

Compared to subcutaneous injection, oral administration significantly reduces the risk of adverse events in middle-aged patients (1864.9 years old)

Developing therapeutic approaches for metachromatic leukodystrophy

Unlike FDA-approved medicines, compounded GLP-1 drugs and products promoted as alternatives to the FDA-approved versions such as oral supplements and patches do not go through the FDAs rigorous review process to ensure safety, effectiveness, and quality